Skip to content

CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.

ASX 200 drifts higher: Afterpay, WiseTech and Appen shares all rise

The ASX 200 witnessed modest gains today, as the Australian blue-chip benchmark played follow-the-leader with Wall Street.

ASX 200 advances Source: Bloomberg

The ASX 200 at a glance

The ASX 200 saw modest gains today, rising some 46 points to hit the 6,563 mark by the close of market. Moderate US Jobs data, a solid Wall Street rally on Friday and the prospect that the US fed will cut rates, all likely played into to the rise witnessed today.

Before the market opened, IG’s Market Analyst, Kyle Rodda; noted that:

‘Investors took a small sigh of relief on Friday night, after US jobs data affirmed that at least for now, the US economy isn’t cascading into recession.’

Yet maybe more importantly, Mr Rodda noted that jobs data:

‘Wasn’t so bad that it signals an imminent contraction for the US economy, yet it was weak enough to maintain the view that the US Fed will have to cut rates very aggressively to manage a tangible slowdown.’

Equity markets are after all, rather fond of rate cuts.

Afterpay and Appen share prices run higher

With the ASX 200 rising modestly today, all sectors finished the session in the green.

Centrally, the information technology sector led today’s gains, with the S&P/ASX 200 Information Technology (XIJ) index rising 1.42%, to hit 1,365 points by the close.

Behind this was the run-up in the proverbial ASX tech darlings: even with no news out these companies, the Afterpay share price rose 2.4%, Appen’s shares gained 2.1% and the WiseTech share price gained 4%.

CSL share price continues upwards

Close behind information technology was health care, with the S&P/ASX 200 Health Care (XHJ) index rising 1.27%, finishing the day some 455 points higher.

Biotech giant CSL contributed significantly to these gains, with its share price gaining 1.29% and reaching A$239 per share. It looks as if investor enthusiasm has persisted, following bullish research from Morgan Stanley that posited CSL’s shares could run-up to A$251.

Such is the self-fulfilling prophecies of broker notes, it would seem.

And the others

Utilities were one of the weakest performing sectors on the ASX today, with the S&P/ASX 200 Utilities (XUJ) index rising just 52 points to reach the 8,028 mark.

Financials also saw a bump, with all of the big four banks rising after spending the last week mostly in the red. Overall, the S&P/ASX 200 Financials index rose 0.37%.

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.

Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Tuesday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.